HROW
Price
$34.22
Change
-$0.21 (-0.61%)
Updated
Dec 20 closing price
80 days until earnings call
ORGO
Price
$3.06
Change
-$0.05 (-1.61%)
Updated
Dec 20, 04:59 PM (EDT)
65 days until earnings call
Ad is loading...

HROW vs ORGO

Header iconHROW vs ORGO Comparison
Open Charts HROW vs ORGOBanner chart's image
Harrow
Price$34.22
Change-$0.21 (-0.61%)
Volume$554.34K
CapitalizationN/A
Organogenesis Holdings
Price$3.06
Change-$0.05 (-1.61%)
Volume$14.22K
CapitalizationN/A
HROW vs ORGO Comparison Chart
Loading...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HROW vs. ORGO commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HROW is a Hold and ORGO is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (HROW: $34.22 vs. ORGO: $3.05)
Brand notoriety: HROW and ORGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: HROW: 101% vs. ORGO: 238%
Market capitalization -- HROW: $467.85M vs. ORGO: $374.78M
HROW [@Pharmaceuticals: Other] is valued at $467.85M. ORGO’s [@Pharmaceuticals: Other] market capitalization is $374.78M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HROW’s FA Score shows that 2 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • HROW’s FA Score: 2 green, 3 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, HROW is a better buy in the long-term than ORGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HROW’s TA Score shows that 4 TA indicator(s) are bullish while ORGO’s TA Score has 3 bullish TA indicator(s).

  • HROW’s TA Score: 4 bullish, 6 bearish.
  • ORGO’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, HROW is a better buy in the short-term than ORGO.

Price Growth

HROW (@Pharmaceuticals: Other) experienced а -3.61% price change this week, while ORGO (@Pharmaceuticals: Other) price change was -10.29% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.34%. For the same industry, the average monthly price growth was -0.19%, and the average quarterly price growth was -10.14%.

Reported Earning Dates

HROW is expected to report earnings on Mar 13, 2025.

ORGO is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-1.34% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HROW($468M) has a higher market cap than ORGO($375M). ORGO has higher P/E ratio than HROW: ORGO (70.25) vs HROW (39.53). HROW YTD gains are higher at: 205.536 vs. ORGO (-25.428). ORGO has higher annual earnings (EBITDA): 36M vs. HROW (9.95M). ORGO has more cash in the bank: 104M vs. HROW (82.8M). ORGO has less debt than HROW: ORGO (119M) vs HROW (191M). ORGO has higher revenues than HROW: ORGO (433M) vs HROW (130M).
HROWORGOHROW / ORGO
Capitalization468M375M125%
EBITDA9.95M36M28%
Gain YTD205.536-25.428-808%
P/E Ratio39.5370.2556%
Revenue130M433M30%
Total Cash82.8M104M80%
Total Debt191M119M161%
FUNDAMENTALS RATINGS
HROW vs ORGO: Fundamental Ratings
HROW
ORGO
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
82
Overvalued
PROFIT vs RISK RATING
1..100
26100
SMR RATING
1..100
9790
PRICE GROWTH RATING
1..100
3861
P/E GROWTH RATING
1..100
1111
SEASONALITY SCORE
1..100
85n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORGO's Valuation (82) in the Financial Conglomerates industry is in the same range as HROW (89) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to HROW’s over the last 12 months.

HROW's Profit vs Risk Rating (26) in the Pharmaceuticals Other industry is significantly better than the same rating for ORGO (100) in the Financial Conglomerates industry. This means that HROW’s stock grew significantly faster than ORGO’s over the last 12 months.

ORGO's SMR Rating (90) in the Financial Conglomerates industry is in the same range as HROW (97) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to HROW’s over the last 12 months.

HROW's Price Growth Rating (38) in the Pharmaceuticals Other industry is in the same range as ORGO (61) in the Financial Conglomerates industry. This means that HROW’s stock grew similarly to ORGO’s over the last 12 months.

HROW's P/E Growth Rating (11) in the Pharmaceuticals Other industry is in the same range as ORGO (11) in the Financial Conglomerates industry. This means that HROW’s stock grew similarly to ORGO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HROWORGO
RSI
ODDS (%)
Bullish Trend 4 days ago
81%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
79%
Momentum
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
87%
MACD
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
78%
Bearish Trend 4 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
85%
Bullish Trend 7 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
88%
View a ticker or compare two or three
Ad is loading...
HROW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LGLVX51.220.89
+1.77%
Lord Abbett Growth Leaders R6
NWHUX30.270.35
+1.17%
Nationwide Bailard Tech & Sci Instl Svc
TCVYX22.730.24
+1.07%
Touchstone Mid Cap Value Y
RYBAX63.580.60
+0.95%
Rydex Basic Materials H
FGDMX111.100.41
+0.37%
Fidelity Advisor Communication ServicesA

ORGO and

Correlation & Price change

A.I.dvisor tells us that ORGO and AMRX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORGO and AMRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-1.93%
AMRX - ORGO
32%
Poorly correlated
+0.39%
HROW - ORGO
30%
Poorly correlated
-0.61%
ACET - ORGO
29%
Poorly correlated
+5.78%
AMPH - ORGO
27%
Poorly correlated
-0.63%
HTSUF - ORGO
26%
Poorly correlated
N/A
More